247 related articles for article (PubMed ID: 26867643)
1. PD-L1-expressing neutrophils as a novel indicator to assess disease activity and severity of systemic lupus erythematosus.
Luo Q; Huang Z; Ye J; Deng Y; Fang L; Li X; Guo Y; Jiang H; Ju B; Huang Q; Li J
Arthritis Res Ther; 2016 Feb; 18():47. PubMed ID: 26867643
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of TIGIT on CD3
Luo Q; Ye J; Zeng L; Li X; Fang L; Ju B; Huang Z; Li J
Allergy Asthma Clin Immunol; 2017; 13():15. PubMed ID: 28261278
[TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical significance of PD-L1 on CD14⁺ monocyte in the peripheral blood of patients with systemic lupus erythematosus].
Xie CH; Wang YY; Li ZJ; Tang J; Li BQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):429-32. PubMed ID: 22482418
[TBL] [Abstract][Full Text] [Related]
4. Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus.
Song LJ; Wang X; Wang XP; Li D; Ding F; Liu HX; Yu X; Li XF; Shu Q
Diagn Pathol; 2015 Jun; 10():71. PubMed ID: 26076826
[TBL] [Abstract][Full Text] [Related]
5. The role and clinical significance of programmed cell death- ligand 1 expressed on CD19
Jia XY; Zhu QQ; Wang YY; Lu Y; Li ZJ; Li BQ; Tang J; Wang HT; Song CW; Xie CH; Chen LJ
Clin Immunol; 2019 Jan; 198():89-99. PubMed ID: 30502542
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
Her M; Kim D; Oh M; Jeong H; Choi I
Lupus; 2009 May; 18(6):501-7. PubMed ID: 19395451
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of TIGIT in NK cells correlates negatively with disease activity in systemic lupus erythematosus.
Luo Q; Li X; Fu B; Zhang L; Deng Z; Qing C; Su R; Xu J; Guo Y; Huang Z; Li J
Int J Clin Exp Pathol; 2018; 11(5):2408-2418. PubMed ID: 31938353
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of soluble programmed cell death protein 1 and soluble programmed cell death protein ligand 2 are increased in systemic lupus erythematosus and associated with the disease activity.
Hirahara S; Katsumata Y; Kawasumi H; Kawaguchi Y; Harigai M
Lupus; 2020 Jun; 29(7):686-696. PubMed ID: 32264742
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of soluble programmed death-1 (sPD-1) and soluble programmed death ligand 1(sPD-L1) in systemic lupus erythematosus: Association with activity and severity.
Du Y; Nie L; Xu L; Wu X; Zhang S; Xue J
Scand J Immunol; 2020 Jul; 92(1):e12884. PubMed ID: 32243638
[TBL] [Abstract][Full Text] [Related]
10. Increased TIM-3
Luo Q; Kong Y; Fu B; Li X; Huang Q; Huang Z; Li J
Clin Exp Med; 2022 Feb; 22(1):47-56. PubMed ID: 34101055
[TBL] [Abstract][Full Text] [Related]
11. The Role of CXC Chemokines in Pulmonary Fibrosis of Systemic Lupus Erythematosus Patients.
Nielepkowicz-Goździńska A; Fendler W; Robak E; Kulczycka-Siennicka L; Górski P; Pietras T; Brzeziańska E; Pietrusińska M; Antczak A
Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):465-73. PubMed ID: 26275808
[TBL] [Abstract][Full Text] [Related]
12. The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study.
Compagno M; Gullstrand B; Jacobsen S; Eilertsen GØ; Nilsson JÅ; Lood C; Jönsen A; Truedsson L; Sturfelt G; Bengtsson AA
Arthritis Res Ther; 2016 Feb; 18():44. PubMed ID: 26860519
[TBL] [Abstract][Full Text] [Related]
13. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of programmed cell death 1 ligand 1 on neutrophils may be involved in sepsis-induced immunosuppression: an animal study and a prospective case-control study.
Wang JF; Li JB; Zhao YJ; Yi WJ; Bian JJ; Wan XJ; Zhu KM; Deng XM
Anesthesiology; 2015 Apr; 122(4):852-63. PubMed ID: 25437496
[TBL] [Abstract][Full Text] [Related]
15. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
16. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
Wong CK; Lit LC; Tam LS; Li EK; Lam CW
Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
[TBL] [Abstract][Full Text] [Related]
17. Association of Serum T cell Immunoglobulin Domain and Mucin-3 and Interleukin-17 with Systemic Lupus Erythematosus.
Jin L; Bai R; Zhou J; Shi W; Xu L; Sheng J; Peng H; Jin Y; Yuan H
Med Sci Monit Basic Res; 2018 Oct; 24():168-176. PubMed ID: 30348938
[TBL] [Abstract][Full Text] [Related]
18. Abnormal membrane-bound and soluble programmed death ligand 2 (PD-L2) expression in systemic lupus erythematosus is associated with disease activity.
Tong M; Fang X; Yang J; Wu P; Guo Y; Sun J
Immunol Lett; 2020 Nov; 227():96-101. PubMed ID: 32891685
[TBL] [Abstract][Full Text] [Related]
19. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
[TBL] [Abstract][Full Text] [Related]
20. Increased serum level of prolactin is related to autoantibody production in systemic lupus erythematosus.
Yang J; Li Q; Yang X; Li M
Lupus; 2016 Apr; 25(5):513-9. PubMed ID: 26678441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
